Cytek Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	75.47	98.72	167.3	296.6	364.62	165.23
Short-Term Investments	186.55	179.15	95.11	44.55	-	-
Cash & Short-Term Investments	262.02	277.86	262.41	341.15	364.62	165.23
Cash Growth	-5.48%	5.89%	-23.08%	-6.44%	120.67%	-
Accounts Receivable	56.23	60.59	55.93	48.86	29.76	16.99
Inventory	49.49	43.89	60.88	48.15	32.17	23.02
Other Current Assets	15.08	14.1	12.85	15.85	5.18	3.38
Total Current Assets	382.83	396.45	392.06	454.02	431.73	208.62
Net Property, Plant & Equipment	34.74	28.13	29.26	27.57	5.85	2.14
Other Intangible Assets	18.6	20.13	23.08	4.33	4.74	0.27
Goodwill	16.71	16.66	16.18	10.14	10.14	0.48
Other Long-Term Assets	40.45	38.13	33.87	23.42	10.84	8.47
Total Assets	493.32	499.5	494.46	519.48	463.31	219.98
Accounts Payable	6.85	5.53	3.03	4.81	3.03	2.94
Accrued Expenses	21.6	21.44	20.04	21.13	15.25	9.05
Unearned Revenue	28.13	25.49	22.7	12.99	7.08	3.67
Other Current Liabilities	16.69	15.2	10.46	10.12	7.82	10.88
Total Current Liabilities	73.27	67.66	56.23	49.04	33.18	26.54
Long-Term Debt	0.79	1.05	1.65	2.27	-	-
Long-Term Leases	14.12	7.55	9.48	12.31	-	-
Other Long-Term Liabilities	27.58	27.5	34.04	30.31	24.74	15.15
Total Long-Term Liabilities	42.49	36.1	45.17	44.89	24.74	15.15
Total Liabilities	115.76	103.76	101.39	93.93	57.92	41.69
Common Stock	0.13	0.13	0.13	0.14	0.13	0.02
Additional Paid-in Capital	429.65	430.79	423.39	442.89	423.63	6.49
Accumulated Other Comprehensive Income	-0.04	0.02	-1.28	-0.7	0.9	0.07
Retained Earnings	-52.18	-35.2	-29.18	-17.03	-19.61	-22.61
Total Common Shareholders' Equity	377.56	395.74	393.06	425.3	405.04	-16.03
Minority Interest	-	-	-	0.25	0.34	194.32
Shareholders' Equity	377.56	395.74	393.06	425.55	405.39	-16.03
Total Liabilities & Equity	493.32	499.5	494.46	519.48	463.31	219.98
Total Debt	14.91	8.6	11.13	14.58	0	0
Net Cash (Debt)	247.11	269.26	251.28	326.57	364.62	165.23
Net Cash Growth	-8.22%	7.15%	-23.05%	-10.44%	120.67%	-
Net Cash Per Share	1.92	2.06	1.86	2.36	4.47	5.07
Book Value	377.56	395.74	393.06	425.3	405.04	-16.03
Book Value Per Share	2.93	3.03	2.91	3.07	4.97	-0.49
Tangible Book Value	342.25	358.95	353.8	410.82	390.16	-16.78
Tangible Book Value Per Share	2.66	2.75	2.62	2.96	4.78	-0.51

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q